Glaucoma: Camille N. Libranda
Glaucoma: Camille N. Libranda
CAMILLE N. LIBRANDA
EPIDEMEOLOGY 2015
International Agency of the
Prevention for Blindness
leading
cause of
irreversible
3rd leading cause of blindness blindness
EPIDEMIOLOGY
Philippines, 2017
14% Cataract
Retinopathy,
33% Maculopathy
, and others
25%
Errors of
Refraction
Glaucoma
28%
ETIOLOGY: Intra ocular
pressure (IOP)
no IOP is not constant;
diagn longer a
ostic it changes with
for gl criterion pulse, blood
auco
ma pressure, forced
expiration or
coughing, neck
compression, and
posture.
fie ld loss
o f visual
ris k
as e s with
incre g IOP
as in
incre
ETIOLOGY
Intraocular Pressure (IOP)
Drugs That May Induce or Potentiate IOP
OPEN-ANGLE GLAUCOMA CLOSED-ANGLE GLAUCOMA
Ophthalmic corticosteroids (high risk) Topical anticholinergics
Systemic corticosteroids Topical sympathomimetics
Nasal/inhaled corticosteroids Systemic anticholinergics
Fenoldopam Heterocyclic antidepressants
Ophthalmic anticholinergics Low-potency phenothiazines
Succinylcholine Antihistamines
Cimetidine (low risk) Ipratropium
Vasodilators (low risk) Benzodiazepines (low risk)
Theophylline (low risk)
PATHOPHYSIOLOGY
The Aqueous humor, dynamics, intraocular pressure (IOP), and Glaucoma
Normal
Primary Secondary Congenital tension
Glaucoma Glaucoma Glaucoma glaucoma
(NGT)
Primary
Angle closure
Open angle
With Without
pupillary pupillary
block block
Secondary
Glaucoma
Trabeculoplasty
Iridotomy
Implants